Related Experiment Video

Updated: Sep 28, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

Miguel A Martínez1, Arantxa Gutiérrez, Mercedes Armand-Ugón

  • 1Retrovirology Laboratory IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.

AIDS (London, England)
|December 4, 2002
PubMed
Abstract

Insights

Short-interfering RNA (siRNA) effectively suppressed HIV co-receptors CXCR4 and CCR5, blocking HIV-1 entry and replication. This gene silencing via RNA interference (RNAi) shows promise for HIV intervention strategies.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Short-interfering RNA (siRNA) mediates gene silencing through RNA interference (RNAi).
  • Chemokine receptors CXCR4 and CCR5 are critical co-receptors for HIV-1 entry.
  • Targeting these co-receptors is a potential strategy for inhibiting HIV infection.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) in suppressing chemokine receptor gene expression.
  • To evaluate the impact of chemokine receptor gene suppression on HIV-1 entry and replication.

Main Methods:

  • Cells were transfected with siRNA targeting CXCR4 and CCR5.
  • HIV co-receptor expression was assessed using flow cytometry and microscopy.
  • HIV entry and replication were measured by intracellular p24 antigen detection and virus production.

Main Results:

  • siRNA targeting CXCR4 and CCR5 significantly reduced cell surface expression and function of these HIV co-receptors.
  • Suppression of CXCR4 and CCR5 by siRNA effectively blocked HIV-1 entry into U87-CD4+ cells.
  • Inhibition of HIV-1 replication was observed in cells treated with siRNA, irrespective of the multiplicity of infection.

Conclusions:

  • RNA interference (RNAi) can effectively block HIV-1 entry and replication by suppressing cellular gene expression.
  • Gene silencing using siRNA represents a potential therapeutic approach for HIV intervention.

More Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

Isolation, Transfection, and Culture of Primary Human Monocytes09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...